Reinforced radiculoplasty for the treatment of symptomatic sacral Tarlov cysts: A clinical analysis of 71 cases.
- Author:
Chao WU
1
;
Bin LIU
1
;
Jing Cheng XIE
1
;
Zhen Yu WANG
1
;
Chang Cheng MA
1
;
Jun YANG
1
;
Jian Jun SUN
1
;
Xiao Dong CHEN
1
;
Tao YU
1
;
Guo Zhong LIN
1
;
Yu SI
1
;
Yun Feng HAN
1
;
Su Hua CHEN
1
;
Xiao Liang YIN
1
;
Qian Quan MA
1
;
Mu Tian ZHENG
1
;
Lin ZENG
2
Author Information
1. Department of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
2. Clinical Epidemiology Research Center, Peking University Third Hospital, Beijing 100191, China.
- Publication Type:Journal Article
- Keywords:
Plastic surgery procedures;
Reinforced radiculoplasty;
Sacral canal;
Tarlov cysts
- MeSH:
Humans;
Tarlov Cysts/epidemiology*;
Retrospective Studies;
Neoplasm Recurrence, Local/complications*;
Cysts/surgery*;
Pain
- From:
Journal of Peking University(Health Sciences)
2023;55(1):133-138
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the safety and efficacy of reinforced radiculoplasty in the treatment of symptomatic sacral Tarlov cysts (TCs).
METHODS:A retrospective analysis was performed on the clinical data and follow-up data of 71 patients with symptomatic sacral TCs who underwent reinforced radiculoplasty in the Neurosurgery Department of Peking University Third Hospital from June 2018 to March 2021. All the operations were performed under neuroelectrophysiological monitoring. Intraoperative cyst exploration, partial resection of the cyst wall, narrowing of the leak, nerve root sleeve radiculoplasty and artificial dural reinforcement were performed. The incidence of postoperative complications and new neurological dysfunction was analyzed. Visual analogue scale (VAS) was used to assess the changes of pain before and after surgery. The Japanese Orthopedics Association (JOA) low back pain score was used to evaluate the changes in nerve function before and after surgery.
RESULTS:In the study, 71 patients had 101 TCs, 19 (18.8%) TCs originated from the left S1 nerve, 26 (25.7%) originated from the left S2 nerve, 3 (3.0%) originated from the left S3 nerve, 14 (13.9%) originated from the right S1 nerve, 33 (32.7%) originated from the right S2 nerve, 6 (5.9%) originated from the right S3 nerve, all the TCs underwent reinforced radiculoplasty. Deep infection (1 case), subcutaneous effusion (1 case), fat li-quefaction (1 case) and urinary tract infection (4 cases) were recorded postoperatively. The patients were followed up for 12-43 months (median, 26 months). Two cases had new urinary retention after operation, and the catheter was removed at the end of the first and second months respectively. One case had new fecal weakness, which improved after 3 months. Compared with preoperation, VAS decreased significantly at the last follow-up [median, 6 (4-9) vs. 1 (0-5), Z=-7.272, P < 0.001], JOA score increased significantly [median, 20 (16-25) vs. 27 (18-29), Z=-7.265, P < 0.001]. There were 18 cured cases (25.4%), 41 excellent cases (57.7%), 8 effective cases (11.3%), and 4 invalid cases (5.6%). The total efficiency was 94.4% (67/71). Two (1.98%) cysts recurred.
CONCLUSION:For patients with symptomatic sacral TCs, reinforced radiculoplasty can significantly improve the pain and nerve function, which is safe and reliable.
